Market Snapshot: Key Equities Under Pressure
U.S. equities experienced sector-specific pressures at midday, with Orla Mining Ltd. (OLA.TO) and Hess Midstream LP (HESM) leading decliners. These movements followed significant corporate strategic shifts and revised analyst assessments, contributing to a bearish sentiment in the affected stocks.
Driving Forces Behind Midday Declines
Orla Mining Ltd. (OLA.TO) shares saw a notable decline of 5.37%, closing at 14.44 CAD on Friday, September 19, 2025. This downturn was primarily triggered by Newmont Corporation (TSX:NGT, NYSE:NEM) selling its entire 13.3% stake in Orla Mining for US$439 million, executed through the Toronto Stock Exchange at US$10.14 (C$14.00) per share. This divestment reduced Orla's market capitalization to approximately US$2.41 billion.
This follows a similar event earlier in September when Agnico Eagle Mines (TSX:AEM, NYSE:AEM) offloaded its 11.3% stake for US$560.5 million. Newmont's CEO, Tom Palmer, stated, "the sale is part of a broader strategy to sharpen focus and free up capital," aligning with the company's ongoing portfolio streamlining efforts.
Concurrently, Hess Midstream LP (NYSE:HESM) shares plunged 10.44% following a disappointing guidance update. This drop reflects investor reaction to Chevron Corp. (NYSE:CVX) reducing its active rig count in the Bakken from four to three, starting in the fourth quarter. This adjustment, post-Chevron's acquisition of Hess assets, is expected to cause oil volumes for HESM to broadly plateau next year, a revision from previous expectations of 5% growth.
Further contributing to the negative sentiment were analyst actions across various companies. Morgan Stanley reduced its price target for General Mills (NYSE:GIS) from $49.00 to $48.00, maintaining an "underweight" rating. Barclays also cut its price objective on General Mills from $60.00 to $54.00. Similarly, The Goldman Sachs Group downgraded General Mills from a "buy" to a "neutral" rating, lowering its target price from $68.00 to $58.00. Raymond James also downgraded 89bio Inc. (NASDAQ:ETNB) from Outperform to Market Perform following Roche’s tender offer to acquire the company, despite a surge in its stock.
Analysis of Market Reaction and Corporate Strategy
The market